CODI-P-B vs RXRX

Comparison between Compass Diversified Holdings (CODI-P-B, Company) and Recursion Pharmaceuticals Inc - Class A (RXRX, Company).

5-Year PerformanceCODI-P-B has outperformed RXRX, delivering a return of +4.6% compared to -35.3%

CODI-P-B vs RXRX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CODI-P-B(COMPANY)	RXRX(COMPANY)
Market Cap	$1.69B	$1.69B
Max Drawdown	53.91%	93.13%
Sharpe Ratio	1.11	-0.47
5Y Beta	0.23	2.63
Industry	Other	Biotechnology
P/E Ratio	-23.54	-3.17
5Y Dividends CAGR	4.56%	N/A
5Y EPS CAGR	N/A	-10.45%
Debt to Equity	464.24%	0.00%
Free Cash Flow Yield	0.60%	-20.81%
P/S Ratio	N/A	25.34
P/B Ratio	N/A	1.55

Market Cap

Winner

CODI-P-B

$1.69B

RXRX

$1.69B

Max Drawdown

Winner

CODI-P-B

53.91%

RXRX

93.13%

Sharpe Ratio

Winner

CODI-P-B

1.11

RXRX

-0.47

5Y Beta

Winner

CODI-P-B

0.23

RXRX

2.63

Industry

CODI-P-B

Other

RXRX

Biotechnology

P/E Ratio

Winner

CODI-P-B

-23.54

RXRX

-3.17

5Y Dividends CAGR

CODI-P-B

4.56%

RXRX

N/A

5Y EPS CAGR

CODI-P-B

N/A

RXRX

-10.45%

Debt to Equity

CODI-P-B

464.24%

Winner

RXRX

0.00%

Free Cash Flow Yield

Winner

CODI-P-B

0.60%

RXRX

-20.81%

P/S Ratio

CODI-P-B

N/A

RXRX

25.34

P/B Ratio

CODI-P-B

N/A

RXRX

1.55

CODI-P-B vs RXRX - Historical Returns

Returns include dividend reinvestment.

Period	CODI-P-B	RXRX
1 month	+0.50%	-16.15%
3 months	+0.51%	-1.53%
6 months	+14.37%	-19.10%
1 year	+28.86%	-40.48%
5 years(CAGR)	+4.59%	-35.29%
10 years(CAGR)	+7.17%	N/A
Max(CAGR)	+7.17%	-34.84%

Winner

CODI-P-B

+0.50%

RXRX

-16.15%

Winner

CODI-P-B

+0.51%

RXRX

-1.53%

Winner

CODI-P-B

+14.37%

RXRX

-19.10%

Winner

CODI-P-B

+28.86%

RXRX

-40.48%

5Y(CAGR)

Winner

CODI-P-B

+4.59%

RXRX

-35.29%

10Y(CAGR)

CODI-P-B

+7.17%

RXRX

N/A

Max(CAGR)

Winner

CODI-P-B

+7.17%

RXRX

-34.84%

CODI-P-B vs RXRX - Annual Returns (2018 - 2026)

Returns include dividend reinvestment.

Year	CODI-P-B	RXRX
2026	+30.02%	-23.33%
2025	-19.19%	-43.27%
2024	+5.44%	-31.51%
2023	+12.08%	+30.60%
2022	-10.58%	-57.24%
2021	+18.18%	-45.27%
2020	+6.78%	N/A
2019	+44.67%	N/A
2018	-18.92%	N/A

CODI-P-B vs RXRX Drawdown Comparison

The maximum drawdown for CODI-P-B was -45.93%, occurring on May 21, 2025. Recovery took 316 trading sessions.

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The current CODI-P-B drawdown is -1.02%. The current RXRX drawdown is -92.21%.

Rank	CODI-P-B	RXRX
#1	-45.93% Jan 16, 2025 - Apr 22, 2026	-93.13% Jul 13, 2021 - Mar 30, 2026
#2	-44.32% Jan 31, 2020 - Nov 16, 2020	-38.10% Apr 29, 2021 - Jun 17, 2021
#3	-25.94% Mar 6, 2018 - Feb 13, 2019	-10.54% Apr 16, 2021 - Apr 21, 2021
#4	-13.09% Aug 2, 2022 - Jun 30, 2023	-10.45% Jun 21, 2021 - Jul 6, 2021
#5	-8.35% Jun 30, 2023 - Jan 26, 2024	-8.29% Apr 21, 2021 - Apr 29, 2021
#6	-7.82% Feb 15, 2019 - Jun 7, 2019	N/A
#7	-7.30% Dec 23, 2021 - Jul 29, 2022	N/A
#8	-5.88% Jul 30, 2024 - Jan 16, 2025	N/A
#9	-4.25% Mar 20, 2024 - Apr 30, 2024	N/A
#10	-3.94% Apr 30, 2024 - Jul 26, 2024	N/A
#11	-3.80% May 20, 2026 - Jun 25, 2026	N/A
#12	-3.79% Sep 29, 2021 - Nov 3, 2021	N/A
#13	-3.71% Nov 10, 2021 - Dec 2, 2021	N/A
#14	-3.66% Apr 23, 2026 - May 20, 2026	N/A
#15	-2.80% Feb 29, 2024 - Mar 20, 2024	N/A

Correlation

Correlation between CODI-P-B and RXRX is -0.33 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.33

-101